Pharmaceuticals, Biotechnology and Life Sciences
The U.S. Food and Drug Administration has approved Bristol-Myers Squibb-marketed Opdivo (nivolumab) to treat patients with advanced form of kidney cancer.
Pfizer and Allergan have entered into a definitive merger agreement under which Pfizer will combine with Allergan in a transaction valued at about $160 billion.
Vertex Pharmaceuticals, a biotechnology company has appointed Pfizer’s Senior Vice president Michael J. Parini to the role of Executive Vice President and Chief Legal Officer.
Diplomat Pharmacy reported on Monday that it is a member of a limited panel of specialty pharmacies selected to distribute Ninlaro as a treatment for patients with relapsed and/or refractory multiple myeloma.
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil…
A medical device company Akers Biosciences has appointed John J. Gormally as Chief Executive Officer from the global medical technology company Becton Dickinson
The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS.
The Swiss-based company Geistlich Pharma AG is recalling batch of Decalcit, vitamin D and calcium chewable tablets, from the market.
Biosense Webster has acquired Coherex Medical, Inc. a privately held medical device company based in Salt Lake City, Utah.
Janssen Research & Development, LLC has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for Invokamet extended release (XR).